Safety, influence on the endometrium, sonographic changes and bleeding profile after 13 cycles with the new drospirenone only pill (DOP) for contraception

20208 citationsJournal Article

Authors

Rossen Koytchev · Cooperative Clinical Drug Research and Development

Wolfram Richter · Cooperative Clinical Drug Research and Development

Abstract

Drospirenone 4 mg film-coated tablet in a dosage regime of 24/4 days is, regarding endometrial histology, a safe drug. Trial registration: EudraCT Register number: 2013-002300-13.

Topics & Keywords

Reproductive Health and Contraception Ectopic Pregnancy Diagnosis and Management Maternal and fetal healthcare

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Hormone Molecular Biology and Clinical Investigation

Volume 42, Issue 2, pp. 123-131

DOI: 10.1515/hmbci-2019-0061

Field-Weighted Citation Impact: 0.89